We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
International Biotechnology Trust Plc | LSE:IBT | London | Ordinary Share | GB0004559349 | ORD 25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 618.00 | 608.00 | 624.00 | 9,368 | 09:22:38 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Trust,ex Ed,religious,charty | 12.06M | 6.81M | 0.1733 | 35.66 | 242.99M |
TIDMIBT
RNS Number : 6435A
Intl. Biotechnology Trust PLC
02 June 2021
2 June 2021
INTERNATIONAL BIOTECHNOLOGY TRUST PLC
("IBT" or the "Company")
Issue of Shares
The Company announces that it has today issued the remaining 43,846 Ordinary shares from treasury at a price of 718.45 pence per Ordinary share and at a premium to the prevailing net asset value.
In addition, the Company also issued 11,154 Ordinary shares of 25 pence each ("Ordinary Shares") pursuant to its block listing facility. The Ordinary Shares were issued at a price of 718.45 pence per Ordinary Share and at a premium to the prevailing net asset value.
Following the issue of the Ordinary Shares, the Company's issued share capital will comprise 41,353,817 Ordinary Shares and this is the total number of Ordinary Shares with voting rights in the Company.
This figure ( 41,353,817 ) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules
For further information contact:
Company Secretary - Link Company Matters
Claire Jackson +44 (0)7821 843993
LEI: 213800N1QUJ744P76D11
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
IOEQLLFBFQLEBBB
(END) Dow Jones Newswires
June 02, 2021 12:51 ET (16:51 GMT)
1 Year International Biotechnol... Chart |
1 Month International Biotechnol... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions